News

ZAS Corporation and BSCCM Host Seminar on Hypophosphatemia and Re-Feeding Syndrome.

ZAS Corporation, in collaboration with the Bangladesh Society of Critical Care Medicine (BSCCM), recently organized a scientific seminar focused on “Hypophosphatemia and Re-feeding Syndrome.” The event featured a compelling case presentation and an interactive Q&A session, marking the successful launch of Polymyxin B. Renowned ICU doctors shared their expert knowledge on the complexities of hypophosphatemia […]

ZAS Corporation and BSCCM Host Seminar on Hypophosphatemia and Re-Feeding Syndrome. Read More »

ZAS Corporation Launches Revolutionary Antibiotic Polymyxin B to Combat Multidrug-Resistant Infections in Bangladesh.

ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division. This potent medication is specifically designed to target and treat serious infections caused by multidrug-resistant gram-negative bacteria, a major concern in healthcare today. The launch event was marked by a comprehensive Training Session for our

ZAS Corporation Launches Revolutionary Antibiotic Polymyxin B to Combat Multidrug-Resistant Infections in Bangladesh. Read More »

ZAS Corporation Ltd. Commits to Advancing Neonatal Care at the 4th International Scientific Conference of Bangladesh Perinatal Society

ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh Perinatal Society, reinforcing its dedication to enhancing neonatal care worldwide. With a firm commitment to the health and well-being of mothers and newborns, ZAS joins forces with esteemed global experts to champion this critical cause. Through collaborative efforts and innovative

ZAS Corporation Ltd. Commits to Advancing Neonatal Care at the 4th International Scientific Conference of Bangladesh Perinatal Society Read More »

Bangladesh Endocrine Society and ZAS Corporation Collaborate to Advance Gonadal Hormone Replacement Therapy Knowledge.

In a groundbreaking collaboration, the Bangladesh Endocrine Society (BES) joined forces with medical experts to conduct a Continuing Medical Education (CME) session delving into the current perspective of Gonadal Hormone Replacement Therapy (GHRT). This significant initiative aimed to enhance understanding and practice in the realm of endocrine health, ultimately striving for improved patient care across

Bangladesh Endocrine Society and ZAS Corporation Collaborate to Advance Gonadal Hormone Replacement Therapy Knowledge. Read More »

ZAS Corporation Ltd. and Bangladesh Lung Foundation Host Scientific Seminar on RTI Prevention

In a promising stride towards combating respiratory infections, ZAS Corporation Ltd. joined hands with the Bangladesh Lung Foundation to pioneer a groundbreaking Scientific Seminar on Recurrent Respiratory Tract Infection (RTI) Prevention. Held in a collaborative effort to explore the potential of Lyophilized Bacterial Lysates, the seminar illuminated innovative pathways for effective healthcare solutions.

ZAS Corporation Ltd. and Bangladesh Lung Foundation Host Scientific Seminar on RTI Prevention Read More »

ZAS Group Launches Five Refreshed & Innovative Websites.

In a thrilling event marking a milestone in healthcare innovation, ZAS Group has unveiled five cutting-edge platforms, bringing healthcare services #CloserThanEver. With the introduction of ZAS Group, ZAS Corporation, ZAS Industries, ZAS Pharma, and ZAS Nutrition, the company is poised to revolutionize the healthcare landscape.

ZAS Group Launches Five Refreshed & Innovative Websites. Read More »

Morinaga Research Centre and Bangladeshi KOL Doctors Forge Path to a ‘Forever Brighter Smile’ in Healthcare Innovation.

Morinaga Research Centre, Japan, joins hands with esteemed KOL Doctors from Bangladesh to pioneer groundbreaking collaborations, aimed at revolutionizing healthcare for a ‘Forever Brighter Smile’. Together, they envision a future where innovative solutions enhance oral health in Bangladesh and beyond. This strategic alliance promises to bring forth transformative advancements, setting new benchmarks in dental care.

Morinaga Research Centre and Bangladeshi KOL Doctors Forge Path to a ‘Forever Brighter Smile’ in Healthcare Innovation. Read More »

ZAS Pharma Unveils Fresh and New Website to Elevate Healthcare Experience.

ZAS Pharma is thrilled to announce the launch of its cutting-edge website, www.zaspharma.com.bd, marking a significant stride in the pursuit of global healthcare excellence. Devoted to the dissemination of top-notch medicines, our platform aims to reach every corner of the world. Join us in commemorating this momentous occasion as our dedicated export team passionately embarks

ZAS Pharma Unveils Fresh and New Website to Elevate Healthcare Experience. Read More »

Dive into the dynamic alliance between ZAS and OM Pharma.

In a groundbreaking alliance, ZAS and OM Pharma recently convened a meeting attended by industry leaders and visionaries, setting the stage for a dynamic partnership in healthcare innovation. The event featured a compelling address from OM Pharma’s Executive Chairman, Etienne Jornod, who eloquently outlined the shared commitment of both entities to revolutionize the healthcare landscape.

Dive into the dynamic alliance between ZAS and OM Pharma. Read More »

ZAS Pharma Ltd. commemorates Epilepsy Awareness Month in November 2023 with the esteemed doctors of BSMMU.

ZAS Pharma Ltd. proudly observes Epilepsy Awareness Month in November 2023, collaborating with the esteemed doctors of Bangabandhu Sheikh Mujib Medical University through their ‘Named Patient Access’ initiative. In a collective effort, they aim to heighten awareness about rare diseases, offering crucial support to those facing these challenges. Heartfelt gratitude is extended to the dedicated

ZAS Pharma Ltd. commemorates Epilepsy Awareness Month in November 2023 with the esteemed doctors of BSMMU. Read More »

Scroll to Top